On November 6, 2025, Amgen, Inc. (“Amgen”) launched a new round of BPCIA denosumab litigations when it filed two cases in the U.S. District Court ...

LDL levels were reduced substantially among heart transplant recipients assigned alirocumab. NEW ORLEANS — In the CAVIAR ...

Alto Neuroscience, Autolus Therapeutics, Ascendis Pharma and Immuneering are gearing up to report Q3 results that could top expectations.

Crispr stock reversed lower Monday, while Intellia stock surged, on promising updates for their gene-editing efforts.

Levelpath, the AI-native intake-to-procure platform that makes procurement delightful, has been recognized in the 2025 Gartner® Innovation Insight: Procurement Orchestration Platforms report.

Pfizer has won the week-long bidding war for Metsera with an upwardly revised up-to-$10 billion offer matching that of rival Novo Nordisk—and more than a little help from Washington.

Merck’s pill, which could be the first oral PCSK9 drug to get to market, displayed similar effects on lipid levels as ...

An oral agent is needed because some patients don’t like injectables, and some doctors don’t prescribe them, experts say.

Quantinuum, the global leader in quantum computing, has unveiled Helios, the most precise general-purpose commercial quantum ...

Amgen, Ciena, and Fair Isaac shine as Zacks' proven stock-ranking strategies continue to outperform amid market uncertainty.

In late-stage studies, Merck & Co.’s PCSK9-targeted pill achieved low-density lipoprotein cholesterol (LDL-C) reductions ...

The 2025 DP World Tour season concludes with the DP World Tour Championship; Rory McIlroy leads the Race to Dubai, with Marco ...